Is vascular endothelial growth factor (VEGF) the main mediator in ovarian hyperstimulation syndrome (OHSS)?

被引：15
|
作者：
Ajonuma, Louis Chukwuemeka [1 ]
机构：
[1] St Marys Matern Hosp, Etiti, Imo State, Nigeria
来源：
MEDICAL HYPOTHESES | 2008年 / 70卷 / 06期
关键词：
D O I：
10.1016/j.mehy.2007.11.004
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Ovarian hyperstimulation syndrome (OHSS) remains one of the most life-threatening and potentially fatal complications of assisted reproduction treatments (ART), due to excessive stimulation of the ovaries by exogenously administrated gonadotropins. The pathogenesis of OHSS remains obscure and patient treatments are empirical. However, vascular endothelial growth factor (VEGF) has been suggested to be responsible for OHSS. The present hypothesis aims to discuss the possible role of epithelial ion channels particularly cystic fibrosis transmembrane conductance regulator (CFTR) involvement in the pathogenesis of OHSS. This may provide grounds for the development of a better treatment strategy to reduce the risk of OHSS and improve in vitro fertilization (IVF) outcome. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1174 / 1178
页数：5
相关论文
共 50 条
  • [21] VASCULAR ENDOTHELIAL GROWTH-FACTOR AS CAPILLARY-PERMEABILITY AGENT IN OVARIAN HYPERSTIMULATION SYNDROME
    MCCLURE, N
    HEALY, DL
    ROGERS, PAW
    SULLIVAN, J
    BEATON, L
    HANING, RV
    CONNOLLY, DT
    ROBERTSON, DM
    LANCET, 1994, 344 (8917): : 235 - 236
  • [22] Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome
    Orvieto, Raoul
    HUMAN REPRODUCTION, 2007, 22 (11) : 3042 - 3042
  • [23] Variations in serum vascular endothelial growth factor binding profiles and the development of ovarian hyperstimulation syndrome
    McElhinney, B
    Ardill, J
    Caldwell, C
    Lloyd, F
    McClure, N
    FERTILITY AND STERILITY, 2002, 78 (02) : 286 - 290
  • [24] Vascular endothelial growth factor antagonist reduces the early onset and the severity of ovarian hyperstimulation syndrome
    Jellad, S.
    Soyah, N.
    Basly, M.
    Chibani, M.
    Rachdi, R.
    HUMAN REPRODUCTION, 2019, 34 : 458 - 459
  • [25] Severe ovarian hyperstimulation syndrome: serum and ascitic fluid concentrations of vascular endothelial growth factor
    Agrawal, R
    Chimusoro, K
    Payne, N
    van der Spuy, Z
    Jacobs, HS
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 1997, 9 (02) : 141 - 144
  • [26] Follicular fluid levels of vascular endothelial growth factor -: Are they predictive markers for ovarian hyperstimulation syndrome
    Geva, E
    Amit, A
    Lessing, JB
    Lerner-Geva, L
    Daniel, Y
    Yovel, I
    Azem, F
    Barak, V
    JOURNAL OF REPRODUCTIVE MEDICINE, 1999, 44 (02) : 91 - 96
  • [27] Vascular endothelial growth factor antagonist reduces the early onset and the severity of ovarian hyperstimulation syndrome
    Jellad, S.
    Hassine, A. Haj
    Basly, M.
    Mrabet, A.
    Chibani, M.
    Rachdi, R.
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2017, 46 (01): : 87 - 91
  • [28] Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome
    Kosaka, Kenzo
    Fujiwara, Hiroshi
    Yoshioka, Shinya
    Fujii, Shingo
    HUMAN REPRODUCTION, 2007, 22 (06) : 1647 - 1651
  • [29] Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation
    Artini, Paolo Giovanni
    Monti, Massimiliano
    Matteucci, Cristiana
    Valentino, Valeria
    Cristello, Francesca
    Genazzani, Andrea Riccardo
    GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (08) : 465 - 470
  • [30] Severe ovarian hyperstimulation syndrome (OHSS) and icterus
    Nawroth, F
    Heinrich, J
    Bruns, U
    Wood, WG
    HUMAN REPRODUCTION, 1996, 11 (11) : 2441 - 2442
12345